Skip to main content
Premium Trial:

Request an Annual Quote

South Africa's CPGR Begins Offering Services Using Affymetrix Microarray Platform

NEW YORK (GenomeWeb News) – South Africa’s Centre for Proteomic and Genomic Research has begun offering genomic research services using Affymetrix’s GeneChip microarray platform, the Santa Clara, Calif.-based company said today.
The company said the center is using many GeneChip arrays, including the exon array and the SNP 6.0 for applications including molecular diagnostics research, large-scale genotyping, and seeking new ways to advance drug research and development in South Africa.
The CPGR, which was founded in 2006, aims to “facilitate high-quality research and enable the growth of existing southern African biotech companies,” the center’s managing director, Reinhard Hiller, said in a statement.
“The range of projects we work on is particularly diverse,” Hiller added, noting that the center would use Affy’s products for toxicology, gene expression, and genotyping studies.
The company did not provide more specifics about its deal with the CPGR, or the financial terms of the agreement.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.